Therapeutic resistance and cancer recurrence mechanisms: Unfolding the story of tumour coming back
- 189 Downloads
Cancer recurrence is believed to be one of the major reasons for the failure of cancer treatment strategies. This biological phenomenon could arise from the incomplete eradication of tumour cells after chemo- and radiotherapy. Recent developments in the design of models reflecting cancer recurrence and in vivo imaging techniques have led researchers to gain a deeper and more detailed insight into the mechanisms underlying tumour relapse. Here, we provide an overview of three important drivers of recurrence including cancer stem cells (CSCs), neosis, and phoenix rising. The survival of cancer stem cells is well recognized as one of the primary causes of therapeutic resistance in malignant cells. CSCs have a relatively latent metabolism and show resistance to therapeutic agents through a variety of routes. Neosis has proven to be as an important mechanism behind tumour self-proliferation after treatment which gives rise to the expansion of tumour cells in the injured site via production of Raju cells. Phoenix rising is a pro-recurrence pathway through which apoptotic cancer cells send strong signals to the neighbouring diseased cells leading to their multiplication. The mechanisms involved in therapeutic resistance and tumour recurrence have not yet been fully understood and mostly remain unexplained. Without doubt, an improved understanding of the cellular machinery contributing to recurrence will pave the way for the development of novel, sophisticated and effective anti-tumour therapeutic strategies which can eradicate tumour without the threat of relapse.
KeywordsCancer recurrence cancer stem cells neosis phoenix rising therapeutic resistance tumour relapse
We are indebted to all of those who provided rich insights into the field. Also, we apologize to the colleagues whose work could not be cited due to space limitations. This work was supported from Tarbiat Modares University, Tehran, Iran.
- Abdullah LN and Chow E 2013 Mechanisms of chemoresistance in cancer stem cells. Clin. Transl. Med. 2(1) 3. doi: 10.1186/2001-1326-2-3
- Bussolati B, Grange C, et al. 2009 Endothelial cell differentiation of human breast tumour stem/progenitor cells. J. Cell Mol. Med. 13 309–319Google Scholar
- Furth J, Kahn MC, et al. 1937 The transmission of leukemia of mice with a single cell. Am. J. Cancer 31 276–282Google Scholar
- Manohar PR 2015 Descriptions and Classification of Cancer in the Classical Ayurvedic Texts. Indian Nat. Sci. Acad. 50 187–195Google Scholar
- Rajaraman R, Guernsey D, et al. 2007 Neosis-A parasexual somatic reduction division in cancer. Int. J. Hum. Genet. 7 29Google Scholar